Ms Myra Garrett > William Fry LLP > Dublin, Ireland > Lawyer Profile

William Fry LLP
2 GRAND CANAL SQUARE
DUBLIN 2
Ireland
Myra Garrett photo

Work Department

Corporate and M&A; Equity Capital Markets.

Position

Myra is a Corporate Partner and former Managing Partner of the Firm. She has a broad corporate practice specialising in corporate finance, particularly mergers & acquisitions, public takeovers, IPOs, public/private fundraisings and corporate structuring. She emerged as a leader via heavy involvement in Nasdaq and Irish Stock Exchange work during the technology boom in the late 1990s and remains one of Ireland’s leading M&A and IPO lawyers. She also advises companies and intermediaries on corporate governance, stock exchange rules, market abuse, the Prospectus Regulations, the Takeover Rules and general compliance.

Memberships

Myra is a non-executive director of the University College Dublin Foundation and a council member of the Irish Institute of Chartered Accountants. She is a former director of the Irish Institute of Directors and of the Irish Road Safety Authority.

Lawyer Rankings

Ireland > Capital markets

(Hall of Fame)

Myra GarrettWilliam Fry LLP

William Fry LLP‘s extensive public company client base provides it with the basis for a thriving ECM practice, while its reputation in the space consistently leads to headline instructions; it advised the Department of Finance on the design and execution of a pre-arranged trading plan for the sale of the state’s shareholding in AIB Group. The team has particular expertise in the real estate, financial services and technology sectors. The firm also boasts a solid DCM and structured finance practice. Mark Talbot and Myra Garrett are top names in the ECM field, with David Maughan standing out in the DCM sector.

Ireland > Commercial, corporate and M&A

(Leading partners)

Myra GarrettWilliam Fry LLP

William Fry LLP has long been a force in corporate transactions, including private and public M&A. In recent times, it has advised on a number of the largest M&A and private equity deals in the market, including Amgen’s headline acquisition of Horizon Therapeutics. The firm has a history of transactions in the healthcare and life sciences, TMT, energy and renewables, financial services and insurance, and real estate sectors. It has also advised on a series of transactions in the data centre sector. Department head Stephen Keogh and public takeovers leader Myra Garrett are top practitioners, along with energy transactions expert Máire O’Neill and technology and life sciences specialist Andrew McIntyre . Mark Talbot is rated for public M&A, while Brian Butterwick has extensive international connections and Mark Quealy  brings further expertise in life sciences, private equity and venture capital.